Medical device firm Specific Diagnostics to set up Amsterdam warehouse and servicing centre
San Jose-based Specific Diagnostics will open a warehouse and servicing centre to serve as a regional depot for repairs and part inventory for the European market.
Specific Diagnostics to set up Amsterdam logistics base
Specific Diagnostics, an American medical device company, is to set up a warehouse and servicing centre in Amsterdam to better reach its European market.
The San Jose firm is partnering with Crane Worldwide Logistics, which also recently expanded in Amsterdam and opened a warehouse facility at Schiphol Logistics Park.
Specific Diagnostics specialises in technology – Reveal Rapid AST – that enables quick de-escalation of antibiotic treatment, helping to prevent antimicrobial resistance in patients (AMR - the ability of bacteria to resist the effects of antibiotics).
Scott O’Brien, CCO of Specific Diagnostics, said: “As the demand for Reveal Rapid AST in Europe is quickly growing, our goal is to ensure white glove service and support to each and every customer."
Jason Stretton, regional vice president Europe at Crane Worldwide Logistics, added: “Specific is an admirable, growing diagnostics company which helps patients all over the world. Crane Worldwide is delighted to partner with Specific to provide integrated logistics solutions in our new Amsterdam facility servicing European operations."
Frontrunner in logistics and life sciences
Home to the Port of Amsterdam and Amsterdam Airport Schiphol, as well as an integrated rail and road network, the Amsterdam Area provides unrivalled and rapid access to European markets.
Next to this, the Netherlands is the top European importer and exporter of medical devices. And, institutions like the Netherlands Center for One Health, which tackles the global risk of infectious diseases, and the Netherlands Antibiotic Development Platform, have established the country as one of Europe’s top three knowledge hubs in the field of AMR.
The Amsterdam Area itself has a thriving life sciences and health industry, driven by the high concentration of research institutions, universities, medical centres, corporations and the European Medicines Agency.